RxDoctor Payments Data

Dante Marra, MD

Orthopaedic Surgery · Triadelphia, WVNPI 1295807725

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.2%), consulting fees and education — rather than concentrated in one kind of arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.8%. Reporting peaked in 2021 at $2,476 and has fallen 83.1% since, to $418 in 2025.

$6,309in general payments, 2019–2025

Across 101 payments — averaging $62.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bone Support Inc.$2K
  • Arthrex$1K
  • Zimmer Biomet$1K
  • Mid-atlantic Surgical Systems, LLC$481
  • Pacira Therapeutics, Inc.$264
  • Vericel Corporation$244
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$1,50024%
  • Travel & lodging$69611%
  • Food & beverage$2,91346%
  • Education$1,20019%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,309 in reported general payments places this provider in the 65th percentile of 93 orthopaedic surgery providers in West Virginia.

See all orthopaedic surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$309,588
Medicare patients
375
Services billed
11,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Potassium18$59,413
Naproxen63$27,999
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen111$724
Meloxicam272$600
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$314
Mupirocin40$212
Tramadol Hcl32$79
Cephalexin29$76

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Triadelphia

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →